← Back to Search

Other

Medium Chain Triglyceride Oil for Mild Cognitive Impairment

N/A
Waitlist Available
Research Sponsored by Pennington Biomedical Research Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baselines to 6 months
Awards & highlights

Study Summary

The primary aim of this study is to assess whether daily dosing with medium chain triglycerides in subjects with mild cognitive impairment (MCI) will improve cognitive performance.

Eligible Conditions
  • Mild Cognitive Impairment

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baselines to 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baselines to 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Improvement in cognitive performance
Secondary outcome measures
Serum Ketones

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Medium Chain Triglyceride OilExperimental Treatment1 Intervention
Differential changes will be compared in the test group versus the control group at one month and six months with respect to BHB and insulin levels, and at six months with respect to cognitive scores.
Group II: Placebo OilPlacebo Group1 Intervention
Differential changes will be compared in the test group versus the control group at one month and six months with respect to BHB and insulin levels, and at six months with respect to cognitive scores.

Find a Location

Who is running the clinical trial?

Pennington Biomedical Research CenterLead Sponsor
305 Previous Clinical Trials
182,032 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Effect of Medium Chain Triglyceride Oil Supplementation in Mild Cognitive Impairment
Jeffrey Keller 2012. "Effect of Medium Chain Triglyceride Oil Supplementation in Mild Cognitive Impairment". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01669200.
~0 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top